TED website is eForms ready from today 02/11/2022. Search changed: please adapt your predefined expert queries. Discover the changes in the site news and in the updated Help Pages

Services - 542205-2019

15/11/2019    S221

United Kingdom-Belfast: Research services

2019/S 221-542205

Contract notice

Services

Legal Basis:
Directive 2014/24/EU

Section I: Contracting authority

I.1)Name and addresses
Official name: Queen's University Belfast
Postal address: University Road
Town: Belfast
NUTS code: UKN NORTHERN IRELAND
Postal code: BT7 1NN
Country: United Kingdom
Contact person: Mrs Gillian Wasson
E-mail: g.wasson@qub.ac.uk
Telephone: +44 2890973026
Internet address(es):
Main address: https://www.qub.ac.uk/directorates/FinanceDirectorate/visitors/procurement/
Address of the buyer profile: https://in-tendhost.co.uk/queensuniversitybelfast
I.3)Communication
Access to the procurement documents is restricted. Further information can be obtained at: https://in-tendhost.co.uk/queensuniversitybelfast
Additional information can be obtained from the abovementioned address
Tenders or requests to participate must be submitted electronically via: https://in-tendhost.co.uk/queensuniversitybelfast
Tenders or requests to participate must be submitted to the abovementioned address
I.4)Type of the contracting authority
Body governed by public law
I.5)Main activity
Education

Section II: Object

II.1)Scope of the procurement
II.1.1)Title:

QUB/1850/19 Contract for Clinical Research Organisation

Reference number: QUB/1850/19
II.1.2)Main CPV code
73110000 Research services
II.1.3)Type of contract
Services
II.1.4)Short description:

Queen's University Belfast seeks to appoint a Clinical Research Organisation (CRO) to provide services in respect of conducting a multinational Phase II study in non-cystic fibrosis BE patients, sponsored by Novartis, across Europe. The trial will be jointly funded by Novartis and the EU Innovative Medicines Initiative (IMI) through the iABC consortium. IMI is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients (http://www.imi.europa.eu/). Access to tender documentation is restricted to those companies who download, complete and submit a CDA to Queen's.

II.1.5)Estimated total value
II.1.6)Information about lots
This contract is divided into lots: no
II.2)Description
II.2.2)Additional CPV code(s)
73110000 Research services
85121200 Medical specialist services
73111000 Research laboratory services
85145000 Services provided by medical laboratories
II.2.3)Place of performance
NUTS code: IT ITALIA
NUTS code: PT PORTUGAL
NUTS code: BE BELGIQUE-BELGIË
NUTS code: FR FRANCE
NUTS code: UK UNITED KINGDOM
NUTS code: AT ÖSTERREICH
NUTS code: CH SCHWEIZ/SUISSE/SVIZZERA
NUTS code: DE DEUTSCHLAND
NUTS code: IE IRELAND
NUTS code: DK DANMARK
NUTS code: NL NEDERLAND
NUTS code: ES ESPAÑA
Main site or place of performance:

The CRO must have the capability to manage a study across multiple EU countries.

II.2.4)Description of the procurement:

Queen's University Belfast seeks to appoint a Clinical Research Organisation (CRO) to provide services in respect of conducting a multinational Phase II study, sponsored by Novartis, across Europe.

II.2.5)Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 24
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: yes
II.2.11)Information about options
Options: yes
Description of options:

This contract includes the option to extend by up to a further 2 years.

II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: yes
Identification of the project:
II.2.14)Additional information

Section III: Legal, economic, financial and technical information

III.1)Conditions for participation
III.1.1)Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers
List and brief description of conditions:

III.1.2)Economic and financial standing
Selection criteria as stated in the procurement documents
III.1.3)Technical and professional ability
Selection criteria as stated in the procurement documents
III.2)Conditions related to the contract
III.2.2)Contract performance conditions:

The CRO must be capable of conducting a randomised Phase II clinical study across Europe. The CRO will not be permitted to sub-contract core services under the funding guidelines and therefore must have the capacity to provide the full suite of services outlined in the specification.

Section IV: Procedure

IV.1)Description
IV.1.1)Type of procedure
Competitive procedure with negotiation
IV.1.3)Information about a framework agreement or a dynamic purchasing system
IV.1.4)Information about reduction of the number of solutions or tenders during negotiation or dialogue
Recourse to staged procedure to gradually reduce the number of solutions to be discussed or tenders to be negotiated
IV.1.5)Information about negotiation
The contracting authority reserves the right to award the contract on the basis of the initial tenders without conducting negotiations
IV.1.8)Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: yes
IV.2)Administrative information
IV.2.2)Time limit for receipt of tenders or requests to participate
Date: 16/12/2019
Local time: 16:00
IV.2.3)Estimated date of dispatch of invitations to tender or to participate to selected candidates
IV.2.4)Languages in which tenders or requests to participate may be submitted:
English

Section VI: Complementary information

VI.1)Information about recurrence
This is a recurrent procurement: no
VI.2)Information about electronic workflows
Electronic ordering will be used
Electronic invoicing will be accepted
Electronic payment will be used
VI.3)Additional information:

Economic operators seeking to obtain tender documentation, must first download, complete and submit a confidential disclosure agreement. Tender documents will not be issued until a completed CDA has been received.

VI.4)Procedures for review
VI.4.1)Review body
Official name: Queen's University Belfast
Postal address: University Road
Town: Belfast
Postal code: BT7 1NN
Country: United Kingdom
Telephone: +44 2890973026
Internet address: https://www.qub.ac.uk/directorates/FinanceDirectorate/Visitors/Procurement/
VI.4.3)Review procedure
Precise information on deadline(s) for review procedures:

This authority will incorporate a standstill period at the point information on the award of the contract is communicated to tenderers. That notification will provide full information on the award decision. The standstill period, which will be for a minimum of 10 calendar days, provides time for unsuccessful tenderers to challenge the award decision before the contract is entered into. The Public Contract Regulations 2015 (SI 2015/102) provide for aggrieved parties who have been harmed or are at risk of harm by a breach of the rules to take action in the High Court (England, Wales and Northern Ireland).

VI.5)Date of dispatch of this notice:
13/11/2019